nodes	percent_of_prediction	percent_of_DWPC	metapath
Isocarboxazid—Inappropriate antidiuretic hormone secretion—Vinblastine—kidney cancer	0.0226	0.0264	CcSEcCtD
Isocarboxazid—Neuritis—Vinblastine—kidney cancer	0.0176	0.0206	CcSEcCtD
Isocarboxazid—Inappropriate antidiuretic hormone secretion—Vincristine—kidney cancer	0.0159	0.0186	CcSEcCtD
Isocarboxazid—Myoclonus—Vincristine—kidney cancer	0.0154	0.018	CcSEcCtD
Isocarboxazid—Neuritis—Vincristine—kidney cancer	0.0124	0.0145	CcSEcCtD
Isocarboxazid—Lethargy—Pazopanib—kidney cancer	0.0123	0.0144	CcSEcCtD
Isocarboxazid—Neuritis—Gemcitabine—kidney cancer	0.0118	0.0137	CcSEcCtD
Isocarboxazid—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—ACHE—kidney cancer	0.011	0.092	CbGpPWpGaD
Isocarboxazid—Lacosamide—CA9—kidney cancer	0.0105	0.427	CrCbGaD
Isocarboxazid—Dysuria—Temsirolimus—kidney cancer	0.0103	0.0121	CcSEcCtD
Isocarboxazid—Pollakiuria—Temsirolimus—kidney cancer	0.0102	0.0119	CcSEcCtD
Isocarboxazid—Myoclonus—Capecitabine—kidney cancer	0.01	0.0117	CcSEcCtD
Isocarboxazid—Neuritis—Paclitaxel—kidney cancer	0.00984	0.0115	CcSEcCtD
Isocarboxazid—Lethargy—Everolimus—kidney cancer	0.0097	0.0113	CcSEcCtD
Isocarboxazid—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—kidney cancer	0.00962	0.0801	CbGpPWpGaD
Isocarboxazid—Amblyopia—Paclitaxel—kidney cancer	0.00951	0.0111	CcSEcCtD
Isocarboxazid—Photosensitivity reaction—Pazopanib—kidney cancer	0.0095	0.0111	CcSEcCtD
Isocarboxazid—Lacosamide—CA2—kidney cancer	0.00947	0.384	CrCbGaD
Isocarboxazid—Urinary retention—Everolimus—kidney cancer	0.00904	0.0106	CcSEcCtD
Isocarboxazid—Coma—Vincristine—kidney cancer	0.00845	0.00988	CcSEcCtD
Isocarboxazid—Chills—Temsirolimus—kidney cancer	0.00793	0.00927	CcSEcCtD
Isocarboxazid—Memory impairment—Capecitabine—kidney cancer	0.00768	0.00898	CcSEcCtD
Isocarboxazid—Dysuria—Everolimus—kidney cancer	0.00768	0.00898	CcSEcCtD
Isocarboxazid—Lethargy—Dactinomycin—kidney cancer	0.00767	0.00897	CcSEcCtD
Isocarboxazid—Pollakiuria—Everolimus—kidney cancer	0.00759	0.00887	CcSEcCtD
Isocarboxazid—Erectile dysfunction—Everolimus—kidney cancer	0.00757	0.00885	CcSEcCtD
Isocarboxazid—Chills—Pazopanib—kidney cancer	0.00747	0.00874	CcSEcCtD
Isocarboxazid—MAOB—Tryptophan metabolism—ALDH1A1—kidney cancer	0.00739	0.0616	CbGpPWpGaD
Isocarboxazid—Neuropathy peripheral—Vinblastine—kidney cancer	0.00721	0.00843	CcSEcCtD
Isocarboxazid—Neuropathy peripheral—Erlotinib—kidney cancer	0.00693	0.0081	CcSEcCtD
Isocarboxazid—MAOA—Biogenic Amine Synthesis—ACHE—kidney cancer	0.00668	0.0556	CbGpPWpGaD
Isocarboxazid—Erectile dysfunction—Sorafenib—kidney cancer	0.00657	0.00768	CcSEcCtD
Isocarboxazid—Hallucination—Everolimus—kidney cancer	0.00654	0.00765	CcSEcCtD
Isocarboxazid—Syncope—Pazopanib—kidney cancer	0.0065	0.0076	CcSEcCtD
Isocarboxazid—Urinary retention—Vincristine—kidney cancer	0.00638	0.00746	CcSEcCtD
Isocarboxazid—Loss of consciousness—Pazopanib—kidney cancer	0.00637	0.00745	CcSEcCtD
Isocarboxazid—Ataxia—Vincristine—kidney cancer	0.00631	0.00738	CcSEcCtD
Isocarboxazid—Neuropathy peripheral—Sorafenib—kidney cancer	0.00623	0.00729	CcSEcCtD
Isocarboxazid—Dry mouth—Pazopanib—kidney cancer	0.00604	0.00706	CcSEcCtD
Isocarboxazid—Neuropathy peripheral—Sunitinib—kidney cancer	0.006	0.00701	CcSEcCtD
Isocarboxazid—Chills—Everolimus—kidney cancer	0.0059	0.0069	CcSEcCtD
Isocarboxazid—Shock—Pazopanib—kidney cancer	0.00582	0.00681	CcSEcCtD
Isocarboxazid—Hyperhidrosis—Pazopanib—kidney cancer	0.00572	0.00669	CcSEcCtD
Isocarboxazid—Chills—Erlotinib—kidney cancer	0.00569	0.00666	CcSEcCtD
Isocarboxazid—Somnolence—Temsirolimus—kidney cancer	0.00558	0.00653	CcSEcCtD
Isocarboxazid—Lethargy—Paclitaxel—kidney cancer	0.00544	0.00636	CcSEcCtD
Isocarboxazid—Dysuria—Vincristine—kidney cancer	0.00543	0.00634	CcSEcCtD
Isocarboxazid—Constipation—Temsirolimus—kidney cancer	0.00537	0.00628	CcSEcCtD
Isocarboxazid—Tremor—Everolimus—kidney cancer	0.00536	0.00627	CcSEcCtD
Isocarboxazid—Erectile dysfunction—Vincristine—kidney cancer	0.00534	0.00625	CcSEcCtD
Isocarboxazid—Paraesthesia—Pazopanib—kidney cancer	0.00531	0.00621	CcSEcCtD
Isocarboxazid—Photosensitivity reaction—Vincristine—kidney cancer	0.0053	0.00619	CcSEcCtD
Isocarboxazid—Agitation—Everolimus—kidney cancer	0.00526	0.00615	CcSEcCtD
Isocarboxazid—Somnolence—Pazopanib—kidney cancer	0.00526	0.00615	CcSEcCtD
Isocarboxazid—Neuritis—Doxorubicin—kidney cancer	0.00521	0.00609	CcSEcCtD
Isocarboxazid—Syncope—Everolimus—kidney cancer	0.00513	0.006	CcSEcCtD
Isocarboxazid—Neuropathy peripheral—Vincristine—kidney cancer	0.00507	0.00593	CcSEcCtD
Isocarboxazid—Palpitations—Everolimus—kidney cancer	0.00506	0.00591	CcSEcCtD
Isocarboxazid—Sleep disorder—Capecitabine—kidney cancer	0.00506	0.00591	CcSEcCtD
Isocarboxazid—Amblyopia—Doxorubicin—kidney cancer	0.00503	0.00588	CcSEcCtD
Isocarboxazid—Loss of consciousness—Everolimus—kidney cancer	0.00503	0.00588	CcSEcCtD
Isocarboxazid—Ataxia—Paclitaxel—kidney cancer	0.00501	0.00586	CcSEcCtD
Isocarboxazid—Photosensitivity—Capecitabine—kidney cancer	0.00498	0.00583	CcSEcCtD
Isocarboxazid—Sweating—Vincristine—kidney cancer	0.00496	0.0058	CcSEcCtD
Isocarboxazid—Syncope—Erlotinib—kidney cancer	0.00495	0.00579	CcSEcCtD
Isocarboxazid—Chills—Sunitinib—kidney cancer	0.00493	0.00576	CcSEcCtD
Isocarboxazid—Orthostatic hypotension—Paclitaxel—kidney cancer	0.00487	0.00569	CcSEcCtD
Isocarboxazid—Loss of consciousness—Erlotinib—kidney cancer	0.00485	0.00568	CcSEcCtD
Isocarboxazid—MAOB—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.00484	0.0403	CbGpPWpGaD
Isocarboxazid—Neuropathy peripheral—Gemcitabine—kidney cancer	0.00481	0.00563	CcSEcCtD
Isocarboxazid—Dry mouth—Everolimus—kidney cancer	0.00477	0.00557	CcSEcCtD
Isocarboxazid—Sweating—Gemcitabine—kidney cancer	0.00471	0.0055	CcSEcCtD
Isocarboxazid—MAOB—Biological oxidations—ACY1—kidney cancer	0.00469	0.0391	CbGpPWpGaD
Isocarboxazid—Benzyl alcohol—CYP1A1—kidney cancer	0.00467	0.189	CrCbGaD
Isocarboxazid—Chills—Dactinomycin—kidney cancer	0.00467	0.00545	CcSEcCtD
Isocarboxazid—Hallucination—Vincristine—kidney cancer	0.00462	0.0054	CcSEcCtD
Isocarboxazid—Shock—Everolimus—kidney cancer	0.0046	0.00537	CcSEcCtD
Isocarboxazid—Hyperhidrosis—Everolimus—kidney cancer	0.00452	0.00528	CcSEcCtD
Isocarboxazid—Lethargy—Capecitabine—kidney cancer	0.00447	0.00522	CcSEcCtD
Isocarboxazid—Syncope—Sorafenib—kidney cancer	0.00446	0.00521	CcSEcCtD
Isocarboxazid—Shock—Erlotinib—kidney cancer	0.00443	0.00518	CcSEcCtD
Isocarboxazid—Loss of consciousness—Sorafenib—kidney cancer	0.00437	0.00511	CcSEcCtD
Isocarboxazid—Dysuria—Paclitaxel—kidney cancer	0.00431	0.00504	CcSEcCtD
Isocarboxazid—Diarrhoea—Temsirolimus—kidney cancer	0.0043	0.00502	CcSEcCtD
Isocarboxazid—Pollakiuria—Paclitaxel—kidney cancer	0.00426	0.00498	CcSEcCtD
Isocarboxazid—Paraesthesia—Vinblastine—kidney cancer	0.00421	0.00492	CcSEcCtD
Isocarboxazid—Photosensitivity reaction—Paclitaxel—kidney cancer	0.00421	0.00492	CcSEcCtD
Isocarboxazid—Paraesthesia—Everolimus—kidney cancer	0.00419	0.0049	CcSEcCtD
Isocarboxazid—Urinary retention—Capecitabine—kidney cancer	0.00416	0.00487	CcSEcCtD
Isocarboxazid—Somnolence—Everolimus—kidney cancer	0.00415	0.00486	CcSEcCtD
Isocarboxazid—Dizziness—Temsirolimus—kidney cancer	0.00415	0.00486	CcSEcCtD
Isocarboxazid—Dry mouth—Sorafenib—kidney cancer	0.00414	0.00484	CcSEcCtD
Isocarboxazid—Ataxia—Capecitabine—kidney cancer	0.00412	0.00481	CcSEcCtD
Isocarboxazid—Diarrhoea—Pazopanib—kidney cancer	0.00405	0.00473	CcSEcCtD
Isocarboxazid—Neuropathy peripheral—Paclitaxel—kidney cancer	0.00403	0.00471	CcSEcCtD
Isocarboxazid—Constipation—Vinblastine—kidney cancer	0.00401	0.00469	CcSEcCtD
Isocarboxazid—Orthostatic hypotension—Capecitabine—kidney cancer	0.004	0.00467	CcSEcCtD
Isocarboxazid—Constipation—Everolimus—kidney cancer	0.00399	0.00467	CcSEcCtD
Isocarboxazid—Shock—Sorafenib—kidney cancer	0.00399	0.00466	CcSEcCtD
Isocarboxazid—Dry mouth—Sunitinib—kidney cancer	0.00398	0.00465	CcSEcCtD
Isocarboxazid—Chills—Gemcitabine—kidney cancer	0.00395	0.00462	CcSEcCtD
Isocarboxazid—MAOA—Melatonin metabolism and effects—ACHE—kidney cancer	0.00394	0.0328	CbGpPWpGaD
Isocarboxazid—Headache—Temsirolimus—kidney cancer	0.00393	0.0046	CcSEcCtD
Isocarboxazid—Dizziness—Pazopanib—kidney cancer	0.00391	0.00457	CcSEcCtD
Isocarboxazid—Constipation—Erlotinib—kidney cancer	0.00385	0.00451	CcSEcCtD
Isocarboxazid—Shock—Sunitinib—kidney cancer	0.00384	0.00449	CcSEcCtD
Isocarboxazid—Nausea—Temsirolimus—kidney cancer	0.00373	0.00436	CcSEcCtD
Isocarboxazid—Agitation—Vincristine—kidney cancer	0.00372	0.00434	CcSEcCtD
Isocarboxazid—Headache—Pazopanib—kidney cancer	0.00371	0.00433	CcSEcCtD
Isocarboxazid—Coma—Doxorubicin—kidney cancer	0.00355	0.00415	CcSEcCtD
Isocarboxazid—Dysuria—Capecitabine—kidney cancer	0.00354	0.00414	CcSEcCtD
Isocarboxazid—Nausea—Pazopanib—kidney cancer	0.00351	0.00411	CcSEcCtD
Isocarboxazid—Paraesthesia—Sunitinib—kidney cancer	0.0035	0.0041	CcSEcCtD
Isocarboxazid—Constipation—Sorafenib—kidney cancer	0.00347	0.00405	CcSEcCtD
Isocarboxazid—Photosensitivity reaction—Capecitabine—kidney cancer	0.00345	0.00404	CcSEcCtD
Isocarboxazid—Constipation—Sunitinib—kidney cancer	0.00334	0.0039	CcSEcCtD
Isocarboxazid—Chills—Paclitaxel—kidney cancer	0.00331	0.00387	CcSEcCtD
Isocarboxazid—Neuropathy peripheral—Capecitabine—kidney cancer	0.00331	0.00387	CcSEcCtD
Isocarboxazid—Photosensitivity—Doxorubicin—kidney cancer	0.00321	0.00376	CcSEcCtD
Isocarboxazid—Diarrhoea—Vinblastine—kidney cancer	0.00321	0.00375	CcSEcCtD
Isocarboxazid—Diarrhoea—Everolimus—kidney cancer	0.0032	0.00374	CcSEcCtD
Isocarboxazid—Hyperhidrosis—Vincristine—kidney cancer	0.00319	0.00373	CcSEcCtD
Isocarboxazid—MAOA—Oxidative Stress—JUNB—kidney cancer	0.00316	0.0264	CbGpPWpGaD
Isocarboxazid—Dizziness—Vinblastine—kidney cancer	0.0031	0.00363	CcSEcCtD
Isocarboxazid—Dizziness—Everolimus—kidney cancer	0.00309	0.00361	CcSEcCtD
Isocarboxazid—Diarrhoea—Erlotinib—kidney cancer	0.00308	0.00361	CcSEcCtD
Isocarboxazid—MAOA—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.00304	0.0253	CbGpPWpGaD
Isocarboxazid—Hyperhidrosis—Gemcitabine—kidney cancer	0.00303	0.00354	CcSEcCtD
Isocarboxazid—Tremor—Paclitaxel—kidney cancer	0.00301	0.00352	CcSEcCtD
Isocarboxazid—Dizziness—Erlotinib—kidney cancer	0.00298	0.00348	CcSEcCtD
Isocarboxazid—Paraesthesia—Vincristine—kidney cancer	0.00296	0.00346	CcSEcCtD
Isocarboxazid—Agitation—Paclitaxel—kidney cancer	0.00295	0.00345	CcSEcCtD
Isocarboxazid—MAOA—Biological oxidations—ACY1—kidney cancer	0.00295	0.0245	CbGpPWpGaD
Isocarboxazid—Headache—Vinblastine—kidney cancer	0.00294	0.00343	CcSEcCtD
Isocarboxazid—Headache—Everolimus—kidney cancer	0.00293	0.00342	CcSEcCtD
Isocarboxazid—Syncope—Paclitaxel—kidney cancer	0.00288	0.00337	CcSEcCtD
Isocarboxazid—Lethargy—Doxorubicin—kidney cancer	0.00288	0.00337	CcSEcCtD
Isocarboxazid—Palpitations—Paclitaxel—kidney cancer	0.00284	0.00332	CcSEcCtD
Isocarboxazid—Headache—Erlotinib—kidney cancer	0.00282	0.0033	CcSEcCtD
Isocarboxazid—Loss of consciousness—Paclitaxel—kidney cancer	0.00282	0.0033	CcSEcCtD
Isocarboxazid—Constipation—Vincristine—kidney cancer	0.00282	0.0033	CcSEcCtD
Isocarboxazid—Paraesthesia—Gemcitabine—kidney cancer	0.00281	0.00329	CcSEcCtD
Isocarboxazid—Nausea—Vinblastine—kidney cancer	0.00279	0.00326	CcSEcCtD
Isocarboxazid—Somnolence—Gemcitabine—kidney cancer	0.00278	0.00325	CcSEcCtD
Isocarboxazid—Nausea—Everolimus—kidney cancer	0.00277	0.00324	CcSEcCtD
Isocarboxazid—Diarrhoea—Sorafenib—kidney cancer	0.00277	0.00324	CcSEcCtD
Isocarboxazid—Chills—Capecitabine—kidney cancer	0.00272	0.00318	CcSEcCtD
Isocarboxazid—Dizziness—Sorafenib—kidney cancer	0.00268	0.00314	CcSEcCtD
Isocarboxazid—Constipation—Gemcitabine—kidney cancer	0.00268	0.00313	CcSEcCtD
Isocarboxazid—Nausea—Erlotinib—kidney cancer	0.00268	0.00313	CcSEcCtD
Isocarboxazid—Dry mouth—Paclitaxel—kidney cancer	0.00267	0.00313	CcSEcCtD
Isocarboxazid—Diarrhoea—Sunitinib—kidney cancer	0.00267	0.00312	CcSEcCtD
Isocarboxazid—MAOB—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.00267	0.0222	CbGpPWpGaD
Isocarboxazid—Ataxia—Doxorubicin—kidney cancer	0.00265	0.0031	CcSEcCtD
Isocarboxazid—MAOB—Tryptophan metabolism—CYP1A1—kidney cancer	0.00262	0.0218	CbGpPWpGaD
Isocarboxazid—Dizziness—Sunitinib—kidney cancer	0.00258	0.00302	CcSEcCtD
Isocarboxazid—Shock—Paclitaxel—kidney cancer	0.00258	0.00302	CcSEcCtD
Isocarboxazid—Orthostatic hypotension—Doxorubicin—kidney cancer	0.00258	0.00301	CcSEcCtD
Isocarboxazid—MAOB—Biological oxidations—ALDH1A1—kidney cancer	0.00257	0.0214	CbGpPWpGaD
Isocarboxazid—Headache—Sorafenib—kidney cancer	0.00254	0.00297	CcSEcCtD
Isocarboxazid—Hyperhidrosis—Paclitaxel—kidney cancer	0.00253	0.00296	CcSEcCtD
Isocarboxazid—Diarrhoea—Dactinomycin—kidney cancer	0.00253	0.00295	CcSEcCtD
Isocarboxazid—Tremor—Capecitabine—kidney cancer	0.00247	0.00289	CcSEcCtD
Isocarboxazid—MAOA—Oxidative Stress—SOD2—kidney cancer	0.00245	0.0204	CbGpPWpGaD
Isocarboxazid—Headache—Sunitinib—kidney cancer	0.00244	0.00286	CcSEcCtD
Isocarboxazid—Nausea—Sorafenib—kidney cancer	0.00241	0.00282	CcSEcCtD
Isocarboxazid—MAOA—Melatonin metabolism and effects—CYP1A1—kidney cancer	0.00238	0.0198	CbGpPWpGaD
Isocarboxazid—Syncope—Capecitabine—kidney cancer	0.00236	0.00276	CcSEcCtD
Isocarboxazid—Paraesthesia—Paclitaxel—kidney cancer	0.00235	0.00275	CcSEcCtD
Isocarboxazid—Somnolence—Paclitaxel—kidney cancer	0.00233	0.00272	CcSEcCtD
Isocarboxazid—Palpitations—Capecitabine—kidney cancer	0.00233	0.00272	CcSEcCtD
Isocarboxazid—Nausea—Sunitinib—kidney cancer	0.00232	0.00271	CcSEcCtD
Isocarboxazid—Loss of consciousness—Capecitabine—kidney cancer	0.00232	0.00271	CcSEcCtD
Isocarboxazid—MAOA—Oxidative Stress—CYP1A1—kidney cancer	0.00232	0.0193	CbGpPWpGaD
Isocarboxazid—Dysuria—Doxorubicin—kidney cancer	0.00228	0.00267	CcSEcCtD
Isocarboxazid—Diarrhoea—Vincristine—kidney cancer	0.00226	0.00264	CcSEcCtD
Isocarboxazid—Pollakiuria—Doxorubicin—kidney cancer	0.00225	0.00263	CcSEcCtD
Isocarboxazid—Constipation—Paclitaxel—kidney cancer	0.00224	0.00262	CcSEcCtD
Isocarboxazid—Photosensitivity reaction—Doxorubicin—kidney cancer	0.00223	0.0026	CcSEcCtD
Isocarboxazid—Dry mouth—Capecitabine—kidney cancer	0.00219	0.00257	CcSEcCtD
Isocarboxazid—Nausea—Dactinomycin—kidney cancer	0.00219	0.00257	CcSEcCtD
Isocarboxazid—Dizziness—Vincristine—kidney cancer	0.00218	0.00255	CcSEcCtD
Isocarboxazid—Drowsiness—Doxorubicin—kidney cancer	0.00217	0.00254	CcSEcCtD
Isocarboxazid—Diarrhoea—Gemcitabine—kidney cancer	0.00214	0.0025	CcSEcCtD
Isocarboxazid—Neuropathy peripheral—Doxorubicin—kidney cancer	0.00213	0.00249	CcSEcCtD
Isocarboxazid—Shock—Capecitabine—kidney cancer	0.00212	0.00247	CcSEcCtD
Isocarboxazid—Sweating—Doxorubicin—kidney cancer	0.00208	0.00244	CcSEcCtD
Isocarboxazid—Hyperhidrosis—Capecitabine—kidney cancer	0.00208	0.00243	CcSEcCtD
Isocarboxazid—Headache—Vincristine—kidney cancer	0.00207	0.00242	CcSEcCtD
Isocarboxazid—Headache—Gemcitabine—kidney cancer	0.00196	0.00229	CcSEcCtD
Isocarboxazid—Nausea—Vincristine—kidney cancer	0.00196	0.00229	CcSEcCtD
Isocarboxazid—Paraesthesia—Capecitabine—kidney cancer	0.00193	0.00226	CcSEcCtD
Isocarboxazid—Nausea—Gemcitabine—kidney cancer	0.00186	0.00217	CcSEcCtD
Isocarboxazid—Constipation—Capecitabine—kidney cancer	0.00184	0.00215	CcSEcCtD
Isocarboxazid—Diarrhoea—Paclitaxel—kidney cancer	0.00179	0.0021	CcSEcCtD
Isocarboxazid—Chills—Doxorubicin—kidney cancer	0.00175	0.00205	CcSEcCtD
Isocarboxazid—Dizziness—Paclitaxel—kidney cancer	0.00173	0.00203	CcSEcCtD
Isocarboxazid—MAOB—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.00172	0.0143	CbGpPWpGaD
Isocarboxazid—MAOA—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.00167	0.0139	CbGpPWpGaD
Isocarboxazid—Headache—Paclitaxel—kidney cancer	0.00164	0.00192	CcSEcCtD
Isocarboxazid—MAOA—Biological oxidations—ALDH1A1—kidney cancer	0.00161	0.0134	CbGpPWpGaD
Isocarboxazid—Agitation—Doxorubicin—kidney cancer	0.00156	0.00183	CcSEcCtD
Isocarboxazid—Nausea—Paclitaxel—kidney cancer	0.00156	0.00182	CcSEcCtD
Isocarboxazid—Syncope—Doxorubicin—kidney cancer	0.00152	0.00178	CcSEcCtD
Isocarboxazid—MAOB—Biological oxidations—GSTT1—kidney cancer	0.00151	0.0126	CbGpPWpGaD
Isocarboxazid—Palpitations—Doxorubicin—kidney cancer	0.0015	0.00176	CcSEcCtD
Isocarboxazid—Loss of consciousness—Doxorubicin—kidney cancer	0.00149	0.00175	CcSEcCtD
Isocarboxazid—Diarrhoea—Capecitabine—kidney cancer	0.00147	0.00172	CcSEcCtD
Isocarboxazid—Dizziness—Capecitabine—kidney cancer	0.00142	0.00166	CcSEcCtD
Isocarboxazid—MAOB—Biological oxidations—PTGS1—kidney cancer	0.00142	0.0118	CbGpPWpGaD
Isocarboxazid—Dry mouth—Doxorubicin—kidney cancer	0.00141	0.00165	CcSEcCtD
Isocarboxazid—Shock—Doxorubicin—kidney cancer	0.00136	0.00159	CcSEcCtD
Isocarboxazid—Headache—Capecitabine—kidney cancer	0.00135	0.00158	CcSEcCtD
Isocarboxazid—Hyperhidrosis—Doxorubicin—kidney cancer	0.00134	0.00157	CcSEcCtD
Isocarboxazid—MAOB—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.00128	0.0107	CbGpPWpGaD
Isocarboxazid—Nausea—Capecitabine—kidney cancer	0.00128	0.00149	CcSEcCtD
Isocarboxazid—Paraesthesia—Doxorubicin—kidney cancer	0.00125	0.00146	CcSEcCtD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—HSPD1—kidney cancer	0.00124	0.0104	CbGpPWpGaD
Isocarboxazid—Somnolence—Doxorubicin—kidney cancer	0.00123	0.00144	CcSEcCtD
Isocarboxazid—Constipation—Doxorubicin—kidney cancer	0.00119	0.00139	CcSEcCtD
Isocarboxazid—MAOA—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.00108	0.00898	CbGpPWpGaD
Isocarboxazid—MAOB—Biological oxidations—GSTP1—kidney cancer	0.00105	0.00873	CbGpPWpGaD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—IL13—kidney cancer	0.00104	0.0087	CbGpPWpGaD
Isocarboxazid—MAOB—Biological oxidations—GSTM1—kidney cancer	0.000963	0.00802	CbGpPWpGaD
Isocarboxazid—Diarrhoea—Doxorubicin—kidney cancer	0.000949	0.00111	CcSEcCtD
Isocarboxazid—MAOA—Biological oxidations—GSTT1—kidney cancer	0.000949	0.0079	CbGpPWpGaD
Isocarboxazid—Dizziness—Doxorubicin—kidney cancer	0.000917	0.00107	CcSEcCtD
Isocarboxazid—MAOB—Biological oxidations—CYP1A1—kidney cancer	0.000913	0.00761	CbGpPWpGaD
Isocarboxazid—MAOA—Biological oxidations—PTGS1—kidney cancer	0.000889	0.00741	CbGpPWpGaD
Isocarboxazid—MAOA—Neuronal System—KCNMA1—kidney cancer	0.000871	0.00726	CbGpPWpGaD
Isocarboxazid—Headache—Doxorubicin—kidney cancer	0.000869	0.00102	CcSEcCtD
Isocarboxazid—MAOA—Transmission across Chemical Synapses—ACHE—kidney cancer	0.000841	0.007	CbGpPWpGaD
Isocarboxazid—Nausea—Doxorubicin—kidney cancer	0.000824	0.000963	CcSEcCtD
Isocarboxazid—MAOA—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000804	0.0067	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—ACY1—kidney cancer	0.000803	0.00669	CbGpPWpGaD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—EGR1—kidney cancer	0.000791	0.00659	CbGpPWpGaD
Isocarboxazid—MAOA—Transmission across Chemical Synapses—BCHE—kidney cancer	0.000732	0.0061	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—PDHB—kidney cancer	0.000683	0.00569	CbGpPWpGaD
Isocarboxazid—MAOB—Biological oxidations—POMC—kidney cancer	0.000681	0.00567	CbGpPWpGaD
Isocarboxazid—MAOA—Biological oxidations—GSTP1—kidney cancer	0.000657	0.00548	CbGpPWpGaD
Isocarboxazid—MAOA—Neuronal System—ACHE—kidney cancer	0.000644	0.00537	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—CCBL1—kidney cancer	0.000642	0.00535	CbGpPWpGaD
Isocarboxazid—MAOA—Biological oxidations—GSTM1—kidney cancer	0.000604	0.00503	CbGpPWpGaD
Isocarboxazid—MAOA—Biological oxidations—CYP1A1—kidney cancer	0.000573	0.00477	CbGpPWpGaD
Isocarboxazid—MAOA—Neuronal System—BCHE—kidney cancer	0.000561	0.00468	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—GLIPR1—kidney cancer	0.000557	0.00464	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—PPAT—kidney cancer	0.000557	0.00464	CbGpPWpGaD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.000551	0.00459	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—APRT—kidney cancer	0.000517	0.00431	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—FH—kidney cancer	0.000517	0.00431	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—ACY1—kidney cancer	0.000504	0.0042	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—GPC3—kidney cancer	0.000486	0.00405	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—CA2—kidney cancer	0.000473	0.00394	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—ALAD—kidney cancer	0.000461	0.00384	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—ST3GAL2—kidney cancer	0.00045	0.00375	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—ALDH1A1—kidney cancer	0.00044	0.00367	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—PDHB—kidney cancer	0.000428	0.00357	CbGpPWpGaD
Isocarboxazid—MAOA—Biological oxidations—POMC—kidney cancer	0.000427	0.00356	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—SLC5A3—kidney cancer	0.000422	0.00351	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—PGK1—kidney cancer	0.000422	0.00351	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—LDHB—kidney cancer	0.000414	0.00345	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—CCBL1—kidney cancer	0.000403	0.00336	CbGpPWpGaD
Isocarboxazid—MAOA—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000374	0.00311	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—CA9—kidney cancer	0.000359	0.00299	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—PPAT—kidney cancer	0.000349	0.00291	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—GLIPR1—kidney cancer	0.000349	0.00291	CbGpPWpGaD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000332	0.00277	CbGpPWpGaD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.00033	0.00275	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—FH—kidney cancer	0.000325	0.0027	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—APRT—kidney cancer	0.000325	0.0027	CbGpPWpGaD
Isocarboxazid—MAOA—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000312	0.0026	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—GPC3—kidney cancer	0.000305	0.00254	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—CRABP1—kidney cancer	0.000305	0.00254	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—CA2—kidney cancer	0.000297	0.00247	CbGpPWpGaD
Isocarboxazid—MAOA—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.00029	0.00242	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—ALAD—kidney cancer	0.000289	0.00241	CbGpPWpGaD
Isocarboxazid—MAOA—Neuronal System—BRAF—kidney cancer	0.000286	0.00239	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—ITPR2—kidney cancer	0.000283	0.00236	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—ST3GAL2—kidney cancer	0.000282	0.00235	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—ALDH1A1—kidney cancer	0.000276	0.0023	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—PGK1—kidney cancer	0.000265	0.0022	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—SLC5A3—kidney cancer	0.000265	0.0022	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—LDHB—kidney cancer	0.00026	0.00216	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—GSTT1—kidney cancer	0.000259	0.00215	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—ACHE—kidney cancer	0.000259	0.00215	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—SCARB1—kidney cancer	0.000245	0.00204	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—PTGS1—kidney cancer	0.000242	0.00202	CbGpPWpGaD
Isocarboxazid—MAOA—Neuronal System—RAF1—kidney cancer	0.000239	0.00199	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—PSMD7—kidney cancer	0.000238	0.00198	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—BCHE—kidney cancer	0.000225	0.00188	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—CA9—kidney cancer	0.000225	0.00187	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—SLC5A5—kidney cancer	0.000222	0.00185	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—SLC2A1—kidney cancer	0.000215	0.00179	CbGpPWpGaD
Isocarboxazid—MAOA—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000214	0.00178	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—CRABP1—kidney cancer	0.000191	0.00159	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—GSTP1—kidney cancer	0.000179	0.00149	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—ITPR2—kidney cancer	0.000178	0.00148	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—ABCB1—kidney cancer	0.00017	0.00141	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—GSTM1—kidney cancer	0.000165	0.00137	CbGpPWpGaD
Isocarboxazid—MAOA—Neuronal System—MAPK1—kidney cancer	0.000164	0.00137	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—GSTT1—kidney cancer	0.000162	0.00135	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—ACHE—kidney cancer	0.000162	0.00135	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—CYP1A1—kidney cancer	0.000156	0.0013	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—SCARB1—kidney cancer	0.000154	0.00128	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—PTGS1—kidney cancer	0.000152	0.00127	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—PSMD7—kidney cancer	0.000149	0.00124	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—BCHE—kidney cancer	0.000141	0.00118	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—SLC5A5—kidney cancer	0.00014	0.00116	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—SLC2A1—kidney cancer	0.000135	0.00112	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—POMC—kidney cancer	0.000116	0.00097	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—GSTP1—kidney cancer	0.000112	0.000937	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—ABCB1—kidney cancer	0.000106	0.000887	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—GSTM1—kidney cancer	0.000103	0.000861	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—CYP1A1—kidney cancer	9.8e-05	0.000816	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—PTGS2—kidney cancer	9.28e-05	0.000773	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—PTEN—kidney cancer	8.1e-05	0.000675	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—POMC—kidney cancer	7.3e-05	0.000608	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—PTGS2—kidney cancer	5.83e-05	0.000485	CbGpPWpGaD
Isocarboxazid—MAOB—Metabolism—PIK3CA—kidney cancer	5.71e-05	0.000476	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—PTEN—kidney cancer	5.08e-05	0.000423	CbGpPWpGaD
Isocarboxazid—MAOA—Metabolism—PIK3CA—kidney cancer	3.58e-05	0.000299	CbGpPWpGaD
